# Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury

> **NCT05303259** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 204 (estimated)

## Conditions studied

- Brain Injuries

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT05303259
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303259, "Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05303259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*